All Notifications

23 hours ago

Financials of Veeda Clinical Research Limited are updated for 2022

23 hours ago

Financials of Veeda Clinical Research Limited are updated for 2023

1 day ago

Veeda, providing a broad range of services across most aspects of the drug development & drug launch throughout global markets has raised capital from Sixth Sense Ventures & others. 

Founded in 2004, Veeda has grown from a single facility in 2004 to now having 4 facilities with a capability to process 1 lakh+ samples monthly. Veeda provides services across drug value chain incl BA/BE studies, full suits of Clinical trials, pharmacokinetics studies & trials in generic molecules, NCEs, large molecules & Biosimilars. 

Till date, Veeda has conducted over 3,500 trials, developed 1,000+ bio-analytical methods spread across generics, NCEs & Biosimilars & completed 85 successful regulatory audits with UK-MHRA, ANVISA & DCGI. The capital raised will be used towards Veeda’s objective of backward as well as forward integration by evaluating inorganic growth opportunities.

Financials of Hindusthan Engineering & Industries Limited Unlisted Shares are updated for 2023

2 days ago

Financials of Electrosteel Steels Limited Unlisted Shares are updated for 2024

Financials of Hindusthan Engineering & Industries Limited Unlisted Shares are updated for 2022

2 days ago

Financials of Royalcare Super Speciality Hospitals are updated for 2023

2 days ago

Financials of Royalcare Super Speciality Hospitals are updated for 2022

2 days ago

Financials of Royalcare Super Speciality Hospitals are updated for 2021

approval of the resolution plan submitted by IndusInd International Holdings Ltd